These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27577200)

  • 1. [Knowledge and willingness of breast cancer patients from Shanghai for genetic counseling and gene testing].
    Cheng X; Li Z; Sun X; Jiang B; Zhuang Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):589-93. PubMed ID: 27577200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of Korean families at high risk for hereditary breast and ovarian cancer in BRCA1/2 genetic testing.
    Sun Y; Kang E; Baek H; Jung J; Hwang E; Koo J; Kim EK; Kim SW
    Jpn J Clin Oncol; 2015 Jun; 45(6):527-32. PubMed ID: 25838294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness of Japanese patients with breast cancer to have genetic testing of BRCA without burden of expenses.
    Nakagomi H; Sakamoto I; Hirotsu Y; Amemiya K; Mochizuki H; Inoue M; Nakagomi S; Kubota T; Omata M
    Breast Cancer; 2016 Jul; 23(4):649-53. PubMed ID: 26025266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' attitudes regarding genetic counseling before germline BRCA1/2 pathogenic variants testing in Taiwan: A single-country, multi-center, patient-reported outcome study.
    Kuo WL; Lin PH; Peng MT; Chu CH; Cho CW
    J Genet Couns; 2023 Aug; 32(4):788-797. PubMed ID: 36872635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary care providers' willingness to recommend BRCA1/2 testing to adolescents.
    O'Neill SC; Peshkin BN; Luta G; Abraham A; Walker LR; Tercyak KP
    Fam Cancer; 2010 Mar; 9(1):43-50. PubMed ID: 19390990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
    Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
    Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population.
    Li D; Shi Y; Li A; Cao D; Su H; Yang H; Zhi Q; Yang Y; Lan Z; Zhou T; You X; Hu G
    Breast Cancer; 2020 Nov; 27(6):1158-1167. PubMed ID: 32566972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the knowledge and attitudes regarding genetic testing for breast cancer risk in our region of southeastern Georgia.
    MacNew HG; Rudolph R; Brower ST; Beck AN; Meister EA
    Breast J; 2010; 16(2):189-92. PubMed ID: 20030654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of genetic counseling and testing for BRCA1 and BRCA2 mutations in African American women: a randomized trial.
    Halbert CH; Kessler L; Troxel AB; Stopfer JE; Domchek S
    Public Health Genomics; 2010; 13(7-8):440-8. PubMed ID: 20234119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Views of Icelandic women towards genetic counseling - and testing of BRCA2 mutations].
    Jonsdottir T; Valdimarsdottir H; Tryggvadottir L; Lund SH; Thordardottir M; Magnusson MK; Valdimarsdottir U
    Laeknabladid; 2018 Juni; 104(6):289-296. PubMed ID: 29863481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.
    Kwong A; Ng EK; Wong CL; Law FB; Au T; Wong HN; Kurian AW; West DW; Ford JM; Ma ES
    PLoS One; 2012; 7(9):e43994. PubMed ID: 22970155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations.
    Elson NC; Wernke K; Yoder LM; Fellner AN; Raque KM; Kuritzky AM; Wexelman BA
    Breast Cancer Res Treat; 2024 Aug; 207(1):25-32. PubMed ID: 38822953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
    Bluman LG; Rimer BK; Regan Sterba K; Lancaster J; Clark S; Borstelmann N; Iglehart JD; Winer EP
    Psychooncology; 2003; 12(5):410-27. PubMed ID: 12833555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Information needs persist after genetic counseling and testing for BRCA1/2 and Lynch Syndrome.
    Peipins LA; Dasari S; Viox MH; Rodriguez JL
    Breast Cancer Res Treat; 2024 Nov; 208(1):19-27. PubMed ID: 39046629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
    Nilsson MP; Törngren T; Henriksson K; Kristoffersson U; Kvist A; Silfverberg B; Borg Å; Loman N
    Breast Cancer Res Treat; 2018 Feb; 168(1):117-126. PubMed ID: 29164420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
    Kemp Z; Turnbull A; Yost S; Seal S; Mahamdallie S; Poyastro-Pearson E; Warren-Perry M; Eccleston A; Tan MM; Teo SH; Turner N; Strydom A; George A; Rahman N
    JAMA Netw Open; 2019 May; 2(5):e194428. PubMed ID: 31125106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2005 Mar; 133A(2):165-9. PubMed ID: 15633195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk.
    Armstrong K; Weber B; Stopfer J; Calzone K; Putt M; Coyne J; Schwartz JS
    Am J Med Genet A; 2003 Mar; 117A(2):154-60. PubMed ID: 12567413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process.
    Wang C; Gonzalez R; Milliron KJ; Strecher VJ; Merajver SD
    Am J Med Genet A; 2005 Apr; 134A(1):66-73. PubMed ID: 15690408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' Attitudes Towards Disclosure of Genetic Test Results to Family Members: The Impact of Patients' Sociodemographic Background and Counseling Experience.
    Gilbar R; Shalev S; Spiegel R; Pras E; Berkenstadt M; Sagi M; Ben-Yehuda A; Mor P; Perry S; Zaccai TF; Borochowitz Z; Barnoy S
    J Genet Couns; 2016 Apr; 25(2):314-24. PubMed ID: 26371363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.